Today: 29 June 2026
XRP price slips under $1.40 as SBI token-bond plan runs into tariff nerves
22 February 2026
2 mins read

XRP price slips under $1.40 as SBI token-bond plan runs into tariff nerves

Karachi, Feb 22, 2026, 22:34 PKT — Regular session

XRP slipped under $1.40 to trade around $1.38 on Sunday, dropping 3.62% in the last day. The Ripple-associated token, currently ranked fourth by market cap, posted a 24-hour trading volume of roughly $1.32 billion with market capitalization hovering near $84.7 billion, according to CoinMarketCap.

The token kept falling, shrugging off news that Japan’s SBI Holdings is gearing up to launch its first security-token bond—a blockchain-based, digitally registered issue that offers XRP perks for subscribers. The 10 billion yen, three-year bond is slated to offer an indicative coupon between 1.85% and 2.45%, backed by a planned A- rating from R&I, with pricing expected March 10. SBI said it’s turning to BOOSTRY’s “ibet for Fin” platform instead of the usual depository setup. The XRP bonus, though, only goes to domestic residents with an SBI VC Trade account who wrap up the required steps by noon on May 11. SBI Group

Macro jitters persist. Trump, reacting to Friday’s Supreme Court tariff decision, hit imports with a fresh 10% tariff—then bumped it up to 15% in under 24 hours, Reuters reported. “The uncertainty, in his view, just gives him enormous additional leverage beyond the actual tariffs,” said Wendy Cutler, a former U.S. trade official now with the Asia Society Policy Institute. Reuters

Bitcoin slipped roughly 1.5% to $67,433.8 on Sunday, according to Investing.com, as earlier momentum fizzled. That move has squeezed out some of the upside for tokens such as XRP, which often exaggerate shifts in the wider market.

Blockchain signals aren’t looking too healthy either. According to Santiment, XRP just posted its biggest realized-loss jump since 2022—realized losses tally up coins dumped at a loss. About 39 months ago, the weekly loss figure hit roughly -$1.93 billion, and over the following eight months, XRP rallied 114%, Santiment noted. Still, the firm was clear: there’s no promise of a quick rebound this time.

XRP moved in a range from about $1.38 up to $1.45 in the past day, tracking the muted action seen in bigger names like ether and solana. Liquidity drops off quickly on weekends, making it easier for even lighter trading to swing prices.

Ripple’s legal standoff with the SEC wrapped up in the U.S. last year, after the agency withdrew its appeal. Ripple walked away with a $125 million civil fine and faces a court-ordered block on institutional sales.

SBI’s bond plan adds to the pile of efforts aimed at funneling crypto incentives into regulated-market structures. But for now, traders continue to position XRP as a high-beta play tied to broader risk sentiment.

There’s a catch, though. Should tariff jitters trigger a bigger risk-off wave when Asian markets open Monday, crypto typically absorbs the blow early—XRP, in particular, tends to swing harder than bitcoin as traders scramble to pare back risk.

Eyes are on the Feb. 23 reopening of Asian cash equity and FX markets, as traders look for ripple effects from tariff news—and any sudden move in bitcoin that might pull XRP out of its tight band.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Fuller Company (FUL) slips under 200-day average as shares drop
    June 29, 2026, 4:47 PM EDT. Shares of Fuller Company (FUL) slid Monday, breaking below the 200-day moving average of $60.50 and touching $59.08. FUL ended off about 6%. The stock last changed hands at $59.18, staying between its 52-week low of $48.71 and high of $68.63. Traders watching technical support took note as FUL lost ground, with dividend stock watchers eyeing the move.
Johnson & Johnson stock falls on DePuy sale talk — what to watch next for JNJ shares
Previous Story

Johnson & Johnson stock falls on DePuy sale talk — what to watch next for JNJ shares

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop